Patent · US Active

Attenuated dengue virus comprising mutations in the NS3 gene

USRE45053E1 · kind E1 · reissue

3Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 2013
Grant dateJul 29, 2014
Priority date
Expiry dateMay 17, 2033

Classification

  • Technology area (CPC —)General

Abstract

A menu of mutations was developed that is useful in fine-tuning the attenuation and growth characteristics of dengue virus vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.